Utama › Kanser Payudara › Minnesota

Kajian klinikal Kanser Payudara di Minnesota

68 kajian untuk Kanser Payudara sedang mencari peserta di lokasi di Minnesota.

Bandar di Minnesota

Teks kajian rasmi (Bahasa Inggeris)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Minnesota Oncology Hematology P A, Minneapolis
Allina Hlth Cancer Inst Minneapolis, Minneapolis

Mengambil pesertaFasa 3

Umur 18 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Riverwood Healthcare Center, Aitkin
Mayo Clinic Health System in Albert Lea, Albert Lea
Essentia Health - Baxter Clinic, Baxter
dan 48 lagi

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Health Partners Frauenshuh Cancer Center, Saint Louis Park
Health Partners Cancer Center at Regions Hospital, Saint Paul

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Mayo Clinic in Rochester, Rochester

Mengambil pesertaFasa 2Sukarelawan sihat dialu-alukan

Umur 18 hingga 45 · Wanita · Dikemas kini 1 Okt 2026 · NCT05557877

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

University of Minnesota, Masonic Cancer Center, Minneapolis
Mayo Clinic, Rochester

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06369285

PRE-ISPY Phase I/II Oncology Platform Program

University of Minnesota Masonic Cancer Center, Minneapolis
Mayo Clinic Comprehensive Cancer Center, Rochester

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05868226

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Mayo Clinic, Rochester

Mengambil peserta

Umur 30 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT02945579

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Saint Paul

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Mayo Clinic Cancer Center, Rochester
HealthPartners Frauenshuh Cancer Center, Saint Louis Park

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07007559

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Minneapolis

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Mayo Clinic, Rochester

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Mayo Clinic in Rochester, Minnesota, Rochester
Metro-Minnesota Community Clinical Oncology, Saint Louis Park

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

Mayo Clinic in Rochester, Minnesota, Rochester

Mengambil pesertaFasa 2

Umur 18 ke atas · Wanita · Dikemas kini 22 Sep 2026 · NCT07287098

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Mayo Clinic - Rochester, Rochester

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213791

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Mayo Clinic, Rochester

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07340541

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Healthpartners Regions Specialty Clinics, Saint Louis Park
Healthpartners Regions Specialty Clinics, Saint Paul

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Mayo Rochester, Rochester

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07109726

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Mayo Clinic Health System - Albert Lea, Albert Lea
Mayo Clinic - Mankato, Mankato
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
dan 2 lagi

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06492616

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

Metro-Minnesota Community Oncology Research Consortium, Saint Paul

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT03424005

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Avera Cancer Institute - Marshall, Marshall

Mengambil pesertaFasa 2

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07405801

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Mayo Clinic, Rochester

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05307705

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Minnesota Oncology-Sarah Cannon Research Institute, Maple Grove

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07287917

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Mayo Clinic, Rochester

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Minnesota Oncology Hematology, P.A., Minneapolis

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06982521

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

University of Minnesota Medical Center, Minneapolis

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06790693

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

University of Minnesota Masonic Cancer Center, Minneapolis

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07216105

The Vanguard Study: Testing a New Way to Screen for Cancer

Minneapolis VA Medical Center, Minneapolis

Mengambil pesertaSukarelawan sihat dialu-alukan

Umur 45 hingga 75 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06995898

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Riverwood Healthcare Center, Aitkin
Essentia Health - Baxter Clinic, Baxter
Sanford Joe Lueken Cancer Center, Bemidji
dan 47 lagi

Mengambil pesertaFasa 3

Umur 18 hingga 60 · Wanita · Dikemas kini 2 Sep 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer

Mayo Clinic, Rochester

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06488378

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Mayo Clinic in Rochester, Rochester

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan

Umur 18 hingga 100 · Wanita · Dikemas kini 27 Ogo 2026 · NCT07207564

A 3D-Printed External Breast Prosthesis for the Improvement of Patient-reported Outcomes Among Breast Cancer Patients That Underwent a Mastectomy Without Reconstruction

Mayo Clinic in Rochester, Rochester

Mengambil peserta

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07047872

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Mayo Clinic in Rochester, Rochester

Mengambil pesertaFasa 3

Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06500481

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Minnesota Oncology Hematology, Maple Grove
Local Institution - 0372, Minneapolis

Mengambil pesertaFasa 2/3

Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06926868

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Minnesota Oncology, Maple Grove

Mengambil pesertaFasa 3

Umur 18 hingga 100 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05232916

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Minnesota Oncology Hematology, Maplewood

Mengambil pesertaFasa 1/2

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT05579366

E-Mindfulness Approaches for Living After Breast Cancer

Essentia Health Saint Joseph's Medical Center, Brainerd
Essentia Health Cancer Center, Duluth
Mayo Clinic Health Systems-Mankato, Mankato
dan 1 lagi

Mengambil pesertaFasa 3

Umur 18 hingga 50 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06748222

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Mayo Clinic in Rochester, Rochester

Mengambil pesertaFasa 1

Umur 18 ke atas · Semua jantina · Dikemas kini 31 Jul 2026 · NCT04521764

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Mayo Clinic Rochester, Rochester

Mengambil pesertaFasa 1

Umur 18 hingga 100 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06562192

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

St. Luke's Hospital, Duluth

Mengambil pesertaFasa 2

Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.